ClinicalTrials.govpublic full text
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
nonalcoholic steatohepatitis, liver diseases, fatty liver disease, liver, nash, nonalcoholic fatty liver disease (nafld), pentoxifylline, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 875075
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.